#143: Dabigatran fatal bleeding less than in trials; obesity paradox in ACCOMPLISH; dulaglutide passes BP hurdle; DIG revisited: digoxin scrutinized anew; LDL-receptor mAb: more impressive data

Dabigatran fatal bleeding less than in trials; obesity paradox in ACCOMPLISH; dulaglutide passes BP hurdle; DIG revisited: digoxin scrutinized anew; LDL-receptor mAb: more impressive data

Source: Radio TheHeart.org - June 1, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts